163 related articles for article (PubMed ID: 29733422)
1. Soluble CD146 and B-type natriuretic peptide dissect overhydration into functional components of prognostic relevance in haemodialysis patients.
Arrigo M; Von Moos S; Gerritsen K; Sadoune M; Tangvoraphonkchai K; Davenport A; Mebazaa A; Segerer S; Cippà PE
Nephrol Dial Transplant; 2018 Nov; 33(11):2035-2042. PubMed ID: 29733422
[TBL] [Abstract][Full Text] [Related]
2. Mathematical model to predict B-type natriuretic peptide levels in haemodialysis patients.
Touzot M; Seris P; Maheas C; Vanmassenhove J; Langlois AL; Moubakir K; Laplanche S; Petitclerc T; Ridel C; Lavielle M
Nephrology (Carlton); 2020 Jan; 25(1):82-89. PubMed ID: 30887608
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor D is a biomarker of fluid overload in haemodialysis patients.
von Moos S; Segerer S; Davenport A; Sadoune M; Gerritsen K; Pottecher J; Ruschitzka F; Mebazaa A; Arrigo M; Cippà PE
Nephrol Dial Transplant; 2021 Feb; 36(3):529-536. PubMed ID: 31923307
[TBL] [Abstract][Full Text] [Related]
4. B-type natriuretic peptide levels and volume status in twice-weekly hemodialysis patients.
Fang N; Che M; Shi L; Yu Z; Ni Z; Fang W; Pang H; Gu L; Lin X
Ren Fail; 2021 Dec; 43(1):1259-1265. PubMed ID: 34465266
[TBL] [Abstract][Full Text] [Related]
5. Relationship of brain natriuretic peptide concentrations to left ventricular function and adverse outcomes in children with end-stage renal disease undergoing hemodialysis.
Ouali S; Bougmiza I; Abroug S; Omezzine A; Ben Salem H; Neffeti E; Remedi F; Bouslema A; Harabi A; Boughzela E
Pediatr Cardiol; 2011 Jun; 32(5):568-77. PubMed ID: 21336977
[TBL] [Abstract][Full Text] [Related]
6. Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient.
Lee SW; Song JH; Kim GA; Lim HJ; Kim MJ
Am J Kidney Dis; 2003 Jun; 41(6):1257-66. PubMed ID: 12776279
[TBL] [Abstract][Full Text] [Related]
7. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
[TBL] [Abstract][Full Text] [Related]
8. Volume estimation in dialysis patients: the concordance of brain-type natriuretic peptide measurements and bioimpedance values.
Tapolyai M; Faludi M; Réti V; Lengvárszky Z; Szarvas T; Fülöp T; Bekő G; Berta K
Hemodial Int; 2013 Jul; 17(3):406-12. PubMed ID: 23362989
[TBL] [Abstract][Full Text] [Related]
9. Plasma Levels of Soluble CD146 Reflect the Severity of Pulmonary Congestion Better Than Brain Natriuretic Peptide in Acute Coronary Syndrome.
Kubena P; Arrigo M; Parenica J; Gayat E; Sadoune M; Ganovska E; Pavlusova M; Littnerova S; Spinar J; Mebazaa A;
Ann Lab Med; 2016 Jul; 36(4):300-5. PubMed ID: 27139601
[TBL] [Abstract][Full Text] [Related]
10. B-type natriuretic peptide and interdialytic fluid retention are independent and incremental predictors of mortality in hemodialysis patients.
Westenbrink BD; Hovinga TK; Kloppenburg WD; Veeger NJ; Janssen WM
Clin Nephrol; 2011 Nov; 76(5):373-9. PubMed ID: 22000557
[TBL] [Abstract][Full Text] [Related]
11. Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: a longitudinal study.
Jacobs LH; van de Kerkhof JJ; Mingels AM; Passos VL; Kleijnen VW; Mazairac AH; van der Sande FM; Wodzig WK; Konings CJ; Leunissen KM; van Dieijen-Visser MP; Kooman JP
Nephrol Dial Transplant; 2010 Jan; 25(1):243-8. PubMed ID: 19692417
[TBL] [Abstract][Full Text] [Related]
12. Fluid overload correction and cardiac history influence brain natriuretic peptide evolution in incident haemodialysis patients.
Chazot C; Vo-Van C; Zaoui E; Vanel T; Hurot JM; Lorriaux C; Mayor B; Deleaval P; Jean G
Nephrol Dial Transplant; 2011 Aug; 26(8):2630-4. PubMed ID: 21273234
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of B-type natriuretic peptide for estimating left atrial size and its usefulness for predicting all-cause mortality and cardiovascular events among chronic haemodialysis patients.
Ishigami J; Iimori S; Kuwahara M; Sasaki S; Tsukamoto Y
Nephrology (Carlton); 2014 Dec; 19(12):777-83. PubMed ID: 25142830
[TBL] [Abstract][Full Text] [Related]
14. Relationship between fluid status as assessed by bioimpedance analysis and NT-pro BNP, blood pressure and left ventricular mass index in hemodialysis patients.
Yilmaz Z; Yildirim Y; Aydin FY; Aydin E; Kadiroglu AK; Yilmaz ME; Ulgen MS; Yildiz A
Clin Ter; 2014; 165(1):e52-8. PubMed ID: 24589961
[TBL] [Abstract][Full Text] [Related]
15. The prognostic role of brain natriuretic peptides in hemodialysis patients.
Naganuma T; Sugimura K; Wada S; Yasumoto R; Sugimura T; Masuda C; Uchida J; Nakatani T
Am J Nephrol; 2002; 22(5-6):437-44. PubMed ID: 12381941
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD146 in the detection and grading of intravascular and tissue congestion in patients with acute dyspnoea: analysis of the prospective observational Lithuanian Echocardiography Study of Dyspnoea in Acute Settings (LEDA) cohort.
Juknevičienė R; Simonavičius J; Mikalauskas A; Čerlinskaitė-Bajorė K; Arrigo M; Juknevičius V; Alitoit-Marrote I; Kablučko D; Bagdonaitė L; Vitkus D; Balčiūnas M; Zuozienė G; Barysienė J; Žaliaduonytė D; Stašaitis K; Kavoliūnienė A; Mebazaa A; Čelutkienė J
BMJ Open; 2022 Sep; 12(9):e061611. PubMed ID: 36581965
[TBL] [Abstract][Full Text] [Related]
17. Brain natriuretic peptide reflects individual variation in hydration status in hemodialysis patients.
Stenberg J; Melin J; Lindberg M; Furuland H
Hemodial Int; 2019 Jul; 23(3):402-413. PubMed ID: 30848066
[TBL] [Abstract][Full Text] [Related]
18. Plasma B-type natriuretic peptide levels reflect the presence and severity of stable coronary artery disease in chronic haemodialysis patients.
Niizuma S; Iwanaga Y; Yahata T; Goto Y; Kita T; Miyazaki S; Nakahama H
Nephrol Dial Transplant; 2009 Feb; 24(2):597-603. PubMed ID: 18762474
[TBL] [Abstract][Full Text] [Related]
19. Brain natriuretic peptide in hemodialysis patients: predictive value for hemodynamic change during hemodialysis and cardiac function.
Matayoshi T; Kato T; Nakahama H; Nakata H; Yoshihara F; Kamide K; Horio T; Nakamura S; Kawano Y
Am J Nephrol; 2008; 28(1):122-7. PubMed ID: 17943021
[TBL] [Abstract][Full Text] [Related]
20. Predicting mortality in haemodialysis patients: a comparison between lung ultrasonography, bioimpedance data and echocardiography parameters.
Siriopol D; Hogas S; Voroneanu L; Onofriescu M; Apetrii M; Oleniuc M; Moscalu M; Sascau R; Covic A
Nephrol Dial Transplant; 2013 Nov; 28(11):2851-9. PubMed ID: 23828163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
